BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33482299)

  • 1. Myriocin modulates the altered lipid metabolism and storage in cystic fibrosis.
    Signorelli P; Pivari F; Barcella M; Merelli I; Zulueta A; Dei Cas M; Rosso L; Ghidoni R; Caretti A; Paroni R; Mingione A
    Cell Signal; 2021 May; 81():109928. PubMed ID: 33482299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
    Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P
    Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic Fibrosis Defective Response to Infection Involves Autophagy and Lipid Metabolism.
    Mingione A; Ottaviano E; Barcella M; Merelli I; Rosso L; Armeni T; Cirilli N; Ghidoni R; Borghi E; Signorelli P
    Cells; 2020 Aug; 9(8):. PubMed ID: 32781626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.
    Caretti A; Bragonzi A; Facchini M; De Fino I; Riva C; Gasco P; Musicanti C; Casas J; Fabriàs G; Ghidoni R; Signorelli P
    Biochim Biophys Acta; 2014 Jan; 1840(1):586-94. PubMed ID: 24141140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ceramide de novo synthesis by myriocin produces the double effect of reducing pathological inflammation and exerting antifungal activity against A. fumigatus airways infection.
    Caretti A; Torelli R; Perdoni F; Falleni M; Tosi D; Zulueta A; Casas J; Sanguinetti M; Ghidoni R; Borghi E; Signorelli P
    Biochim Biophys Acta; 2016 Jun; 1860(6):1089-97. PubMed ID: 26922830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.
    Caretti A; Vasso M; Bonezzi FT; Gallina A; Trinchera M; Rossi A; Adami R; Casas J; Falleni M; Tosi D; Bragonzi A; Ghidoni R; Gelfi C; Signorelli P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):775-790. PubMed ID: 28439630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
    Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
    Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
    Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CFTR Deletion Confers Mitochondrial Dysfunction and Disrupts Lipid Homeostasis in Intestinal Epithelial Cells.
    Kleme ML; Sané A; Garofalo C; Seidman E; Brochiero E; Berthiaume Y; Levy E
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29954133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells.
    Bhura-Bandali FN; Suh M; Man SF; Clandinin MT
    J Nutr; 2000 Dec; 130(12):2870-5. PubMed ID: 11110839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.
    Luciani A; Villella VR; Esposito S; Gavina M; Russo I; Silano M; Guido S; Pettoello-Mantovani M; Carnuccio R; Scholte B; De Matteis A; Maiuri MC; Raia V; Luini A; Kroemer G; Maiuri L
    Autophagy; 2012 Nov; 8(11):1657-72. PubMed ID: 22874563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.
    John G; Yildirim AO; Rubin BK; Gruenert DC; Henke MO
    Am J Respir Cell Mol Biol; 2010 Apr; 42(4):424-31. PubMed ID: 19502387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis.
    Ruffin M; Voland M; Marie S; Bonora M; Blanchard E; Blouquit-Laye S; Naline E; Puyo P; Le Rouzic P; Guillot L; Corvol H; Clement A; Tabary O
    Biochim Biophys Acta; 2013 Dec; 1832(12):2340-51. PubMed ID: 24080196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR.
    Zhang S; Stoll G; Pedro JMBS; Sica V; Sauvat A; Obrist F; Kepp O; Li Y; Maiuri L; Zamzami N; Kroemer G
    Cell Death Dis; 2018 Feb; 9(2):191. PubMed ID: 29415993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid metabolism in cystic fibrosis.
    Worgall TS
    Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):105-9. PubMed ID: 19209467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis.
    White NM; Jiang D; Burgess JD; Bederman IR; Previs SF; Kelley TJ
    Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L476-86. PubMed ID: 17085523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress modulates the expression of genes involved in cell survival in ΔF508 cystic fibrosis airway epithelial cells.
    Voisin G; Bouvet GF; Legendre P; Dagenais A; Massé C; Berthiaume Y
    Physiol Genomics; 2014 Sep; 46(17):634-46. PubMed ID: 24893876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myriocin treatment affects lipid metabolism in skeletal muscles of rats with streptozotocin-induced type 1 diabetes.
    Kurek K; Garbowska M; Ziembicka DM; Łukaszuk B; Rogowski J; Chabowski A; Górski J; Żendzian-Piotrowska M
    Adv Med Sci; 2017 Mar; 62(1):65-73. PubMed ID: 28189121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy augmentation alleviates cigarette smoke-induced CFTR-dysfunction, ceramide-accumulation and COPD-emphysema pathogenesis.
    Bodas M; Pehote G; Silverberg D; Gulbins E; Vij N
    Free Radic Biol Med; 2019 Feb; 131():81-97. PubMed ID: 30500419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Ceramide Synthesis Reduces α-Synuclein Proteinopathy in a Cellular Model of Parkinson's Disease.
    Mingione A; Pivari F; Plotegher N; Dei Cas M; Zulueta A; Bocci T; Trinchera M; Albi E; Maglione V; Caretti A; Bubacco L; Paroni R; Bottai D; Ghidoni R; Signorelli P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.